For example, the integrated analysis function of the prostate cancer organoids-on-a-chip can rapidly detect fluctuations in prostate cancer-related epigenetic biomarkers (RASSF1, APC, and RARb gene hypermethylation) before and after drug administration. This evidence concerns the gene RASSF1 and prostate carcinoma.